Insight Molecular Diagnostics Inc. (IMDX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 30.52M | 15.31M | 21.39M | 26.84M | 36.26M | 11.76M | 4.79M | 9.97M | 6.54M | 10.7M | 16.92M | 20.98M |
| Cash & Short-Term Investments | 28.2M | 11.58M | 18.69M | 24.29M | 31.03M | 8.64M | 3.36M | 9.26M | 5.58M | 9.43M | 14.22M | 17.9M |
| Cash Only | 28.2M | 11.58M | 18.69M | 24.29M | 31.03M | 8.64M | 3.36M | 9.26M | 5.58M | 9.43M | 13.78M | 17.37M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 441K | 530K |
| Accounts Receivable | 157K | 1.13M | 258K | 512K | 3.54M | 1.61M | 209K | 85K | 161K | 484K | 1.88M | 1.72M |
| Days Sales Outstanding | 1.81K | 55.98 | 136.23 | 355.92 | 108.46 | 56.4 | 117.6 | 107.63 | 166.75 | 346.61 | 385.8 | 355.45 |
| Inventory | 382K | 446K | 471K | 693K | 459K | 410K | 232K | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 58.45 | 65.6 | 442.51 | 312 | 48.1 | 33.14 | 328.37 | - | - | - | - | - |
| Other Current Assets | 1.78M | 2.15M | 1.97M | 1.35M | 1.24M | 1.1M | 989K | 627K | 61K | 782K | 811K | 1.37M |
| Total Non-Current Assets | 9.91M | 10.45M | 22.55M | 23.68M | 24.1M | 23.32M | 65.42M | 64.75M | 64.44M | 64.19M | 64.67M | 66.56M |
| Property, Plant & Equipment | 2.46M | 2.81M | 2.34M | 2.52M | 7.16M | 2.76M | 3M | 5.94M | 5.73M | 5.44M | 5.83M | 7.89M |
| Fixed Asset Turnover | 0.01x | 0.44x | 0.11x | 0.11x | 0.43x | 0.52x | 0.03x | 0.02x | 0.03x | 0.06x | 0.06x | 0.06x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 14.6M | 14.6M | 14.6M | 14.61M | 56.53M | 56.55M | 56.57M | 56.59M | 56.62M | 56.64M |
| Long-Term Investments | 0 | 607K | 0 | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 0 | 0 | 0 | 1.7M |
| Other Non-Current Assets | 7.45M | 7.03M | 5.61M | 4.85M | 642K | 4.26M | 4.19M | 563K | 2.14M | 2.16M | 2.22M | 329K |
| Total Assets | 40.43M | 25.76M | 43.94M | 50.52M | 60.36M | 35.08M | 70.22M | 74.72M | 70.97M | 74.89M | 81.59M | 87.54M |
| Asset Turnover | 0.00x | 0.03x | 0.01x | 0.01x | 0.04x | 0.03x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x |
| Asset Growth % | -33.02% | -26.58% | -37.43% | -32.39% | -14.95% | -53.16% | -13.94% | -14.64% | -14.28% | -25.18% | -48.15% | -48.82% |
| Total Current Liabilities | 12.01M | 12.07M | 7.66M | 6.65M | 9.68M | 7.28M | 9.09M | 7.2M | 8.33M | 7.19M | 8.03M | 7.67M |
| Accounts Payable | 1.61M | 2.54M | 1.06M | 1.28M | 2.28M | 2.28M | 872K | 1.05M | 908K | 953K | 1.14M | 875K |
| Days Payables Outstanding | 293.58 | 257.54 | 886.93 | 963.08 | 252.29 | 162.68 | 1.36K | 1.65K | 646.38 | 234.95 | 511.08 | 540.76 |
| Short-Term Debt | 1.76M | 0 | 1.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 737K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.63M | 7.72M | 5.01M | 3.83M | 2.96M | 2.17M | 6.93M | 3.81M | 2.31M | 4.01M | 4.13M | 4.75M |
| Current Ratio | 2.54x | 1.27x | 2.79x | 4.04x | 3.75x | 1.62x | 0.53x | 1.38x | 0.78x | 1.49x | 2.11x | 2.74x |
| Quick Ratio | 2.51x | 1.23x | 2.73x | 3.93x | 3.70x | 1.56x | 0.50x | 1.38x | 0.78x | 1.49x | 2.11x | 2.74x |
| Cash Conversion Cycle | 1.57K | -135.97 | -308.18 | -295.16 | -95.73 | -73.13 | -914.92 | - | - | - | - | - |
| Total Non-Current Liabilities | 39.11M | 45.15M | 45.47M | 42.77M | 40.46M | 40.08M | 51.41M | 44.82M | 45.73M | 47.23M | 35.99M | 31.55M |
| Long-Term Debt | 1.31M | 0 | 1.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 1.69M | 0 | 1.83M | 2.07M | 2.37M | 2.71M | 2.64M | 2.51M | 2.2M | 2.35M | 2.4M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 37.81M | 43.45M | 43.94M | 40.93M | 38.38M | 37.71M | 48.71M | 42.18M | 43.21M | 45.03M | 33.64M | 29.15M |
| Total Liabilities | 51.12M | 57.22M | 53.13M | 49.42M | 50.14M | 47.35M | 60.51M | 52.02M | 54.05M | 54.42M | 44.02M | 39.22M |
| Total Debt | 3.07M | 3.5M | 3.13M | 3.37M | 3.48M | 3.66M | 3.99M | 3.67M | 3.33M | 2.87M | 3.07M | 3.13M |
| Net Debt | -25.13M | -8.09M | -15.56M | -20.91M | -27.55M | -4.97M | 628K | -5.59M | -2.24M | -6.56M | -10.71M | -14.23M |
| Debt / Equity | - | - | - | 3.07x | 0.34x | - | 0.41x | 0.16x | 0.20x | 0.14x | 0.08x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -449.17x | -881.88x | -373.28x | -388.68x | -229.03x | -1116.03x | -434.26x | -565.25x | -607.60x | -31.61x | -462.50x | -594.21x |
| Total Equity | -10.69M | -31.46M | -9.2M | 1.1M | 10.22M | -12.27M | 9.71M | 22.7M | 16.92M | 20.47M | 37.56M | 48.33M |
| Equity Growth % | -204.63% | -156.35% | -194.7% | -95.16% | -39.61% | -159.97% | -74.15% | -53.02% | -55.4% | -48.31% | -51.13% | -45.15% |
| Book Value per Share | -0.31 | -1.03 | -0.29 | 0.03 | 0.40 | -0.71 | 0.71 | 1.76 | 2.05 | 2.48 | 4.55 | 5.97 |
| Total Shareholders' Equity | -10.69M | -31.46M | -9.2M | 1.1M | 10.22M | -12.27M | 9.71M | 22.7M | 16.92M | 20.47M | 37.56M | 48.33M |
| Common Stock | 394.29M | 369.21M | 368.52M | 367.96M | 367.39M | 338.24M | 326.68M | 326.2M | 310.55M | 310.3M | 310M | 309.54M |
| Retained Earnings | -405.05M | -400.76M | -377.81M | -366.95M | -357.21M | -350.54M | -317.03M | -303.54M | -299M | -289.88M | -272.46M | -265.98M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 71K | 86K | 86K | 85K | 41K | 21K | 57K | 37K | 40K | 49K | 32K | 41K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |